Navigation Links
Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Date:9/24/2008

REINACH, Switzerland, September 24 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) today announced the completion of enrolment in the Phase II 'intravenous-to-oral' switch trial with oral iclaprim in patients with complicated Skin and Skin Structure Infections (cSSSI).

The trial was designed as a multi-centre, double-blind comparative study. Patients suffering from cSSSI received intravenous (IV) vancomycin for the first two days of treatment and were then randomised to either continue to receive IV vancomycin or to be switched to oral iclaprim for eight additional days. A total of 60 patients have been randomised for this study.

The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with IV vancomycin in the treatment of cSSSI. The primary endpoint is the clinical cure rate at the Test-of-Cure (TOC) visit. Secondary objectives include bacteriological outcome as well as safety and tolerability.

Dr Paul Hadvary, Head of Development of Arpida Ltd., commented: "The speed of enrolment in this Phase II trial surpassed our expectations. It again shows that an 'intravenous-to-oral' step-down therapy serves a medical need and could add significant value to intravenous iclaprim. Marketing applications for intravenous iclaprim have been filed in the U.S.A., the European Union and Canada. We will release the top-line data of this Phase II switch study in the coming months and subsequently determine the path ahead."

About Arpida Ltd.

Arpida (SWX: ARPN) is a biopharmaceutical company headquartered in Reinach, Switzerland with operations in Switzerland and the USA. It focuses on the discovery, development and commercialisation of novel drugs that seek to overcome the growing problem of microbial resistance. The most advanced compounds include an antibacterial under regulatory review and an antifungal in Phase III.

Arpida's leading product can
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced today that ... present at the LD MICRO "MAIN Event" Micro-Cap Growth ... be held at the Luxe Sunset Bel Air Hotel, ... Los Angeles, California . The ...
(Date:11/24/2014)... Calif. , Nov. 24, 2014  Rigel Pharmaceuticals, Inc. ... Gower is retiring from the board of directors and ... Raul Rodriguez , most recently serving as the company,s ... chief executive officer and join the board of directors.  ... since 2005, will become chairman. Mr. Gower is expected to ...
(Date:11/23/2014)... 2014  Aurobindo Pharma USA ... 300 mg 100-count bottles to the consumer level. The ... capsules. Empty capsules could result in missed ... could range from no effect, short term reduction in ... period seizures) that could be life-threatening. Aurobindo Pharma ...
Breaking Medicine Technology:Relmada Therapeutics To Present At LD MICRO Conference 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2
... Wis., Oct. 26 Shopko is pleased to announce the ... President/GMM of Apparel and Accessories. He will have primary responsibility ... business and marketing plans. , Csuy joined Shopko in ... 2008. He added Men,s apparel to his responsibilities in December ...
... Thousands of Clinical Cardiovascular Practices to Promote Practice ... 26 The American College of Cardiology today ... first-ever registry-based cardiovascular network to link thousands of ... ACC,s National Cardiovascular Data Registry(R) (NCDR), the preeminent ...
Cached Medicine Technology:Csuy Named Senior Vice President/General Merchandise Manager 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 3
(Date:11/24/2014)... Residents of retirement communities in Ohio and ... GOT TALENT, an annual online talent competition and showcase ... classic crooners, to seniors partying on a “night on ... living young. , “SENIORS GOT TALENT, while still having ... has always been about highlighting the vibrancy of being ...
(Date:11/24/2014)... SWAccessControl.com has recently released a new ... fact, the company is a leading online supplier in the ... are available at discounted prices, up to 30% off. , ... locks. This time, all of our items are offered at ... abroad, so I have confidence in our fresh assortment. You ...
(Date:11/24/2014)... Y, New York (PRWEB) November 24, 2014 ... announced today that it has received national Tier recognition in ... Law Firms.” Achieving a tiered ranking signals a unique combination ... “We are very proud to receive this honor and especially ... has made this important honor and ranking possible,” said Jeff ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
Breaking Medicine News(10 mins):Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Close Friends May Be Key to Teens' Drinking 2
... a condition that leads to inflammation of the liver is ... of abusers are suffering from // the disease in the ... interest in determining the effects of drug abuse, specifically opiates, ... association would impact treatment of both HCV infection and drug ...
... Reddy Union Minister of Information, Broadcasting and Culture, India ... public regarding the prevention and treatment of HIV infections. ... social relevance. The media could play an important role ... the different broadcasting tools such as radio, websites, SMS, ...
... Security in the United States has established that more than ... This accounts for a 43 % increase over the last ... outcome,' noted center director Dr. J. Larry Brown, a leading ... so long after the recession ended means that it is ...
... the October issue of the journal Hepatology, a diet ... including reduced levels of NKT cells, in the livers ... liver regulate production of cytokines, which are cell proteins. ... obesity -related liver disease. ,The researchers found that ...
... Paruresis manifests in an inability to urinate in public ... to be published in the Journal of Anxiety ... on the assumption that paruresis is a form of ... pure social phobic subjects only in the severity of ...
... Miniature robots may soon replace surgeons, more so in space ... in length and about a cm wide and have wheels ... into a cavity and surgeons in different locations can ... functions – some have lights and camera on them while ...
Cached Medicine News:Health News:Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers 2Health News:Obesity As A Contributor To Liver Disease 2Health News:Shy Bladder Syndrome: A Social Phobia Or Functional Disorder Of Micturition? 2Health News:Remote Robotic Surgery Using Miniature Robots 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: